Id2 represses E2A-mediated activation of IL-10 expression in T cells

Blood

Volumn 123, Issue 22, 2014, Pages 3420-3428

  Masson, Frederick ^a,b   Ghisi, Margherita ^c   Groom, Joanna R ^a,b   Kallies, Axel ^a,b   Seillet, Cyril ^a,b   Johnstone, Ricky W ^b,c   Nutt, Stephen L ^a,b   Belz, Gabrielle T ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME B; INHIBITOR OF DIFFERENTIATION 2; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 21; MESSENGER RNA; STAT3 PROTEIN; STAT4 PROTEIN; TRANSCRIPTION FACTOR E2A; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENHANCER REGION; GENE LOCUS; IMMUNOPATHOLOGY; INFLUENZA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; WILD TYPE;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE MARROW; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENETIC LOCI; GRAFT VS HOST DISEASE; INHIBITOR OF DIFFERENTIATION PROTEIN 2; INTERLEUKIN-10; MICE; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; T-LYMPHOCYTE SUBSETS; TRANSCRIPTIONAL ACTIVATION;

EID: 84901699999     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-03-561456     Document Type: Article

References (38)

1. Markey KA, MacDonald KP, Hill GR. Impact of cytokine gene polymorphisms on graft-vs-host disease. Tissue Antigens. 2008;72(6):507-516.
2. Lin MT, Storer B, Martin PJ, et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med. 2003;349(23):2201-2210. (Pubitemid 37485136)
3. Lin MT, Storer B, Martin PJ, et al. Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor. Blood. 2005; 106(12):3995-4001. (Pubitemid 41739044)
4. Sun J, Madan R, Karp CL, Braciale TJ. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med. 2009;15(3):277-284.
5. Perona-Wright G, Kohlmeier JE, Bassity E, et al. Persistent loss of IL-27 responsiveness in CD81 memory T cells abrogates IL-10 expression in a recall response. Proc Natl Acad Sci USA. 2012; 109(45):18535-18540.
6. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683-765. (Pubitemid 32368050)
7. Fahey LM, Brooks DG. Opposing positive and negative regulation of T cell activity during viral persistence. Curr Opin Immunol. 2010;22(3): 348-354.
8. Tussiwand R, Lee WL, Murphy TL, et al. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature. 2012;490(7421):502-507.
9. Apetoh L, Quintana FJ, Pot C, et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol. 2010; 11(9):854-861.
10. Li P, Spolski R, Liao W, et al. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature. 2012;490(7421):543-546.
11. Motomura Y, Kitamura H, Hijikata A, et al. The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD41 T cells. Nat Immunol. 2011;12(5):450-459.
12. Iwasaki Y, Fujio K, Okamura T, et al. Egr-2 transcription factor is required for Blimp-1- mediated IL-10 production in IL-27-stimulated CD41 T cells. Eur J Immunol. 2013;43(4): 1063-1073.
13. Cretney E, Xin A, Shi W, et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat Immunol. 2011;12(4):304-311.
14. Sun J, Dodd H, Moser EK, Sharma R, Braciale TJ. CD41 T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat Immunol. 2011;12(4):327-334.
15. Lee CG, Kang KH, So JS, et al. A distal cisregulatory element, CNS-9, controls NFAT1 and IRF4-mediated IL-10 gene activation in T helper cells. Mol Immunol. 2009;46(4):613-621.
16. Cannarile MA, Lind NA, Rivera R, et al. Transcriptional regulator Id2 mediates CD81 T cell immunity. Nat Immunol. 2006;7(12): 1317-1325. (Pubitemid 46111253)
17. Masson F, Minnich M, Olshansky M, et al. Id2-mediated inhibition of E2A represses memory CD81 T cell differentiation. J Immunol. 2013; 190(9):4585-4594.
18. Knell J, Best JA, Lind NA, Yang E, D'Cruz LM, Goldrath AW. Id2 influences differentiation of killer cell lectin-like receptor G1(hi) short-lived CD81 effector T cells. J Immunol. 2013;190(4): 1501-1509.
19. Kee BLE. E and ID proteins branch out. Nat Rev Immunol. 2009;9(3):175-184.
20. Seillet C, Jackson JT, Markey KA, et al. CD8a1 DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3. Blood. 2013;121(9):1574-1583.
21. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell. 1994;76(1):17-27. (Pubitemid 24035278)
22. Hennet T, Hagen FK, Tabak LA, Marth JD. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by sitedirected recombination. Proc Natl Acad Sci USA. 1995;92(26):12070-12074.
23. Kamanaka M, Kim ST, Wan YY, et al. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity. 2006;25(6):941-952. (Pubitemid 44894945)
24. Mittr ücker HW, Matsuyama T, Grossman A, et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science. 1997;275(5299):540-543. (Pubitemid 27051911)
25. Belz GT, Xie W, Altman JD, Doherty PC. A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virusspecific CD8(1) T-cell response is much less apparent following secondary challenge. J Virol. 2000;74(8):3486-3493. (Pubitemid 30180290)
26. Mielke LA, Groom JR, Rankin LC, et al. TCF-1 controls ILC2 and NKp461RORgt1 innate lymphocyte differentiation and protection in intestinal inflammation. J Immunol. 2013;191(8): 4383-4391.
27. Spolski R, Kim HP, Zhu W, Levy DE, Leonard WJ. IL-21 mediates suppressive effects via its induction of IL-10. J Immunol. 2009;182(5): 2859-2867.
28. Saraiva M, Christensen JR, Veldhoen M, Murphy TL, Murphy KM, O'Garra A. Interleukin-10 production by Th1 cells requires interleukin-12- induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity. 2009;31(2):209-219.
29. Stumhofer JS, Silver JS, Laurence A, et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol. 2007;8(12):1363-1371. (Pubitemid 350131173)
30. D'Cruz LM, Lind KC, Wu BB, Fujimoto JK, Goldrath AW. Loss of E protein transcription factors E2A and HEB delays memory-precursor formation during the CD81 T-cell immune response. Eur J Immunol. 2012;42(8):2031-2041.
31. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, et al. Interleukin-10 dose-dependent regulation of CD41 and CD81 T cell-mediated graft-versushost disease. Transplantation. 1998;66(9): 1220-1229. (Pubitemid 28530328)
32. Blazar BR, Taylor PA, Smith S, Vallera DA. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts. Blood. 1995;85(3):842-851.
33. Mumm JB, Emmerich J, Zhang X, et al. IL-10 elicits IFNg-dependent tumor immune surveillance. Cancer Cell. 2011;20(6):781-796.
34. O'Garra A, Barrat FJ, Castro AG, Vicari A, Hawrylowicz C. Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev. 2008;223:114-131. (Pubitemid 351986180)
35. van der Stoep N, Quinten E, Marcondes Rezende M, van den Elsen PJ. E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII). Blood. 2004;104(9):2849-2857. (Pubitemid 39434971)
36. Lazorchak AS, Schlissel MS, Zhuang Y. E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells. Mol Cell Biol. 2006;26(3):810-821. (Pubitemid 43146477)
37. Sun J, Cardani A, Sharma AK, et al. Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus. PLoS Pathog. 2011; 7(8):e1002173.
38. Cui W, Liu Y, Weinstein JS, Craft J, Kaech SM. An interleukin-21- interleukin-10-STAT3 pathway is critical for functional maturation of memory CD81 T cells. Immunity. 2011;35(5):792-805.